Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Legacy Housing | LEGH | 27. sep 2024 | 27.41 | -0.36 |
LegalZoom.com | LZ | 27. sep 2024 | 6.47 | -2.12 |
Legato Merger III | LEGT | 27. sep 2024 | 10.21 | +0.04 |
Legend Biotech ADR | LEGN | 27. sep 2024 | 49.27 | +5.17 |
Legg Mason Low Volatility High Dividend ETF | LVHD | 27. sep 2024 | 40.55 | +0.52 |
Leggett & Platt | LEG | 27. sep 2024 | 14.12 | +3.75 |
Leidos | LDOS | 27. sep 2024 | 159.72 | +0.81 |
LeMaitre Vascular | LMAT | 27. sep 2024 | 91.71 | +1.57 |
Lemonade | LMND | 27. sep 2024 | 16.95 | -0.59 |
LendingClub | LC | 27. sep 2024 | 11.03 | +2.13 |
LendingTree | TREE | 27. sep 2024 | 56.42 | +0.97 |
Lendway | LDWY | 27. sep 2024 | 3.57 | +1.39 |
Lennar A | LEN | 27. sep 2024 | 187.03 | +2.17 |
Lennar B | LEN-B | 27. sep 2024 | 172.14 | +2.70 |
Lennox International | LII | 27. sep 2024 | 604.87 | -1.77 |
LENSAR | LNSR | 27. sep 2024 | 4.44 | +0.68 |
LENZ Therapeutics | LENZ | 27. sep 2024 | 24.04 | +8.04 |
Leonardo DRS | DRS | 27. sep 2024 | 27.87 | +0.36 |
Lesaka Technologies | LSAK | 27. sep 2024 | 4.89 | -2.40 |
Leslies | LESL | 27. sep 2024 | 2.86 | +0.35 |
Levi Strauss & Co A | LEVI | 27. sep 2024 | 21.65 | +0.89 |
Lexaria Bioscience | LEXX | 27. sep 2024 | 3.02 | +1.68 |
Lexeo Therapeutics | LXEO | 27. sep 2024 | 9.11 | +2.24 |
Lexicon Pharmaceuticals | LXRX | 27. sep 2024 | 1.60 | +3.90 |
LexinFintech ADR | LX | 27. sep 2024 | 2.39 | +16.59 |
LG Display ADR | LPL | 27. sep 2024 | 4.23 | -0.70 |
LGI Homes | LGIH | 27. sep 2024 | 117.74 | +3.46 |
LGL Group | LGL | 27. sep 2024 | 6.04 | +4.86 |
Li Auto ADR | LI | 27. sep 2024 | 25.78 | +1.62 |
Li-Cycle | LICY | 27. sep 2024 | 2.11 | +0.96 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.